S1NN34.SA Smith & Nephew plc

Healthcare Medical Devices Sao Paulo Exchange
33.00 BRL
Close of Nov 5, 2026
27.42 37.29
Market cap
BRL 69.1B
P/E
21.2x
P/B
2.45x
ROE
11.8%
Dividend yield
2.40%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is S1NN34.SA undervalued?

Graham number
Price33.00
Graham value21.74
Premium51.8%

S1NN34.SA trades 51.8% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Smith & Nephew plc fundamental analysis

No fundamental analysis for Smith & Nephew plc yet.

Smith & Nephew plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Smith & Nephew plc

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used i…

Full company profile